Artificial Intelligence for Benign Esophageal Stricture Dilation: An Evidence‐Transferability Framework and Safety‐First Roadmap

ABSTRACT Background Endoscopic dilation is first‐line therapy for symptomatic benign esophageal strictures but remains operator‐dependent. Artificial intelligence (AI) could support assessment, risk stratification, and documentation; however, evidence from adjacent tasks is often mistaken for procedure‐specific validation. Aim To map the evidence for AI in benign esophageal stricture dilation, assess transferability and methodological quality, and propose a translational pathway. Methods We searched PubMed/MEDLINE, Scopus, and Europe PMC from inception through June 28, 2026, using prespecified searches in adults and children. Studies were classified by evidence provenance and appraised using design‐adapted domain considerations. Results Within the search date and eligibility criteria, no AI system was identified that guided, monitored, or assessed dilation itself; two retrospective single‐center studies applied machine learning in the target population for other tasks. Adjacent neoplasia and engineering studies support component feasibility, while clinical cohorts identify candidate predictors. Functional lumen imaging probe technology provides non‐AI measurement and potential reference labels. Recurrent concerns included selected or retrospective samples, limited external validation, and high concern about applicability to dilation. Performance cannot be transferred across mismatched target tasks, acquisition physics, reference standards, populations or operating contexts, or consequences of error. Conclusion Adjacent evidence can justify candidate components. Procedure‐specific calibration and validation remain necessary. Priorities are calibrated morphometric variables with prespecified reference standards and reproducible documentation using synchronized multimodal and outcome data. External validation should be followed by human‐controlled advisory testing before intraprocedural automation.

Authors

Institutions

Publication Details

Journal
AI & Innovation
Published
2026-10-13
DOI
https://doi.org/10.1002/aiv2.70019
Primary Topic
Esophageal and GI Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Intelligence for Benign Esophageal Stricture Dilation: An Evidence‐Transferability Framework and Safety‐First Roadmap

Mohamed Abdalla Salman, Ahmed Salman
AI & Innovation
Esophageal and GI Pathology
article

Artificial Intelligence for Benign Esophageal Stricture Dilation: An Evidence‐Transferability Framework and Safety‐First Roadmap

Mohamed Abdalla Salman, Ahmed Salman
article en

Abstract

ABSTRACT Background Endoscopic dilation is first‐line therapy for symptomatic benign esophageal strictures but remains operator‐dependent. Artificial intelligence (AI) could support assessment, risk stratification, and documentation; however, evidence from adjacent tasks is often mistaken for procedure‐specific validation. Aim To map the evidence for AI in benign esophageal stricture dilation, assess transferability and methodological quality, and propose a translational pathway. Methods We searched PubMed/MEDLINE, Scopus, and Europe PMC from inception through June 28, 2026, using prespecified searches in adults and children. Studies were classified by evidence provenance and appraised using design‐adapted domain considerations. Results Within the search date and eligibility criteria, no AI system was identified that guided, monitored, or assessed dilation itself; two retrospective single‐center studies applied machine learning in the target population for other tasks. Adjacent neoplasia and engineering studies support component feasibility, while clinical cohorts identify candidate predictors. Functional lumen imaging probe technology provides non‐AI measurement and potential reference labels. Recurrent concerns included selected or retrospective samples, limited external validation, and high concern about applicability to dilation. Performance cannot be transferred across mismatched target tasks, acquisition physics, reference standards, populations or operating contexts, or consequences of error. Conclusion Adjacent evidence can justify candidate components. Procedure‐specific calibration and validation remain necessary. Priorities are calibrated morphometric variables with prespecified reference standards and reproducible documentation using synchronized multimodal and outcome data. External validation should be followed by human‐controlled advisory testing before intraprocedural automation.

AI & Innovation
Cairo University (EG)
Openalex Percentile: Top 10%
Esophageal and GI Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.